NxGenPort
2 known investors
NXgenPort is developing a smart implantable chemotherapy port that integrates optical sensing and machine learning to monitor blood cell dynamics and other physiological changes in vivo, paired with a digital health platform for data analysis. It targets oncology care teams and cancer patients, aiming to detect treatment complications like infection and neutropenia early for remote patient monitoring.
Founders & leadership
CS
Cathy SkinnerCo-founder/Co-inventor & Chief Executive Officer
RW
Rosanne WelcherCo-founder/Co-inventor & Chief Operating Officer
Investors · 2
Frequently asked questions
- What does NxGenPort do?
- NXgenPort is developing a smart implantable chemotherapy port that integrates optical sensing and machine learning to monitor blood cell dynamics and other physiological changes in vivo, paired with a digital health platform for data analysis. It targets oncology care teams and cancer patients, aiming to detect treatment complications like infection and neutropenia early for remote patient monitoring.
- Who founded NxGenPort?
- NxGenPort was founded by Cathy Skinner, Rosanne Welcher.
- Who are NxGenPort's investors?
- NxGenPort's investors include Cancer Fund, GROOVE CAPITAL.